Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.36 |
| ▸ | BAD | Q92934 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16219587 | 0.89 | MEN1 (0.50) | MEN1KMT2AALDH1A1MAPTKDM4E | |
| SCHEMBL12836956 | 0.89 | MEN1 (0.43) | MEN1KMT2AALDH1A1MAPTKDM4E | |
| SCHEMBL16065516 | 0.85 | MEN1 (0.43) | MEN1KMT2ATDP1MAOACA2 | |
| SCHEMBL24924048 | 0.84 | MEN1 (0.42) | MEN1KMT2AALDH1A1MAPTKDM4E | |
| SCHEMBL1524545 | 0.78 | MEN1 (0.38) | MEN1KMT2AMAOA | |
| SCHEMBL12793222 | 0.78 | MEN1 (0.38) | MEN1KMT2AMAOA | |
| SCHEMBL29488431 | 0.78 | MEN1 (0.38) | MEN1KMT2AMAOA | |
| SCHEMBL12057393 | 0.77 | MEN1 (0.61) | MEN1KMT2AALDH1A1MAPTKDM4E | |
| SCHEMBL12224023 | 0.75 | MEN1 (0.50) | MEN1KMT2AALDH1A1MAPTKDM4E | |
| SCHEMBL14136627 | 0.74 | MEN1 (0.32) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4707264-A2 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | Verbio SE (DE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4122924-B1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | VERBIO SE (DE) | 2025-11-19 | — | — | EP | disclosed |
| US-12065450-B2 | Compounds and the use thereof in metathesis reactions | VERBIO SE (DE) | 2024-08-20 | — | — | US | disclosed |
| US-11664093-B2 | Extrapolative prediction of enantioselectivity enabled by computer-driven workflow, new molecular representations and machine learning | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-05-30 | — | — | US | disclosed |
| US-11664093-B2 | Extrapolative prediction of enantioselectivity enabled by computer-driven workflow, new molecular representations and machine learning | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-05-30 | — | — | US | disclosed |
| US-11664093-B2 | Extrapolative prediction of enantioselectivity enabled by computer-driven workflow, new molecular representations and machine learning | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-05-30 | — | — | US | disclosed |
| EP-4122924-A2 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | Verbio Vereinigte BioEnergie AG (DE) | 2023-01-25 | — | — | EP | disclosed |
| US-20230013959-A1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | VERBIO SE (DE) | 2023-01-19 | — | — | US | disclosed |
| US-11414446-B1 | Compounds and the use thereof in metathesis reactions | VERBIO VEREINIGTE BIOENERGIE AG | 2022-08-16 | — | — | US | disclosed |
| EP-3129365-B1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | VERBIO VER BIOENERGIE AG (DE) | 2022-05-04 | — | — | EP | disclosed |
| US-20150152332-A1 | LIQUID CRYSTAL COMPOSITION, POLYMER, FILM, AND CHOLESTERIC LIQUID CRYSTAL | FUJIFILM CORPORATION (JP) | 2015-06-04 | — | — | US | disclosed |
| US-20150152332-A1 | LIQUID CRYSTAL COMPOSITION, POLYMER, FILM, AND CHOLESTERIC LIQUID CRYSTAL | FUJIFILM CORPORATION (JP) | 2015-06-04 | — | — | US | disclosed |
| US-20120323000-A1 | Z-SELECTIVE RING-CLOSING METATHESIS REACTIONS | TRUSTEES OF BOSTON COLLEGE (US) | 2012-12-20 | — | — | US | disclosed |
| US-20110065915-A1 | CATALYSTS FOR METATHESIS REACTIONS INCLUDING ENANTIOSELECTIVE OLEFIN METATHESIS, AND RELATED METHODS | TRUSTEES OF BOSTON COILEGE (MA) | 2011-03-17 | — | — | US | disclosed |
| US-7517828-B2 | Chiral broensted acid catalyst for asymmetric synthesis and method of asymmetric synthesis with the catalyst | TOAGOSEI CO., LTD. (JP) | 2009-04-14 | — | — | US | disclosed |
| US-20080188657-A1 | CHEMICAL PROCESS | ASTRAZENECA UK LIMITED (GB) | 2008-08-07 | — | — | US | disclosed |
| US-20080188657-A1 | CHEMICAL PROCESS | ASTRAZENECA UK LIMITED (GB) | 2008-08-07 | — | — | US | disclosed |
| WO-2008065410-A1 | PROCESS FOR THE PREPARATION OF ROSUVASTATIN | ASTRAZENECA UK LIMITED (GB) | 2008-06-05 | — | — | WO | disclosed |
| US-20060276329-A1 | Asymmetric synthesis catalyst based on chiral brsnsted acid and method of asymmetric synthesis with the catalyst | TOAGOSEI CO., LTD. (JP) | 2006-12-07 | — | — | US | disclosed |
| EP-1623971-A1 | ASYMMETRIC-SYNTHESIS CATALYST BASED ON CHIRAL BROENSTED ACID AND METHOD OF ASYMMETRIC SYNTHESIS WITH THE CATALYST | TOAGOSEI CO., LTD. (JP) | 2006-02-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065915-A1 | CATALYSTS FOR METATHESIS REACTIONS INCLUDING ENANTIOSELECTIVE OLEFIN METATHESIS, AND RELATED METHODS | SQLE, ICMT, COASY | MEN1 729/4885KMT2A 1423/4885ALDH1A1 443/4885 |
| US-20080188657-A1 | CHEMICAL PROCESS | HMGCR, CYP4A11, ACSL4 | MEN1 2050/4885KMT2A 3239/4885ALDH1A1 158/4885 |
| US-11414446-B1 | Compounds and the use thereof in metathesis reactions | PRMT6, CYP2D6, POR | MEN1 1230/4885KMT2A 2495/4885ALDH1A1 1286/4885 |
| US-20120323000-A1 | Z-SELECTIVE RING-CLOSING METATHESIS REACTIONS | ZYX, ZDHHC7, ZDHHC2 | MEN1 432/4885KMT2A 1195/4885ALDH1A1 1620/4885 |
| US-12065450-B2 | Compounds and the use thereof in metathesis reactions | PRMT6, CYP2D6, POR | MEN1 1230/4885KMT2A 2495/4885ALDH1A1 1286/4885 |
| US-20060276329-A1 | Asymmetric synthesis catalyst based on chiral brsnsted acid and method of asymmetric synthesis with the catalyst | LSS, COASY, FASN | MEN1 169/4885KMT2A 2039/4885ALDH1A1 1508/4885 |
| US-20230013959-A1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | PRMT6, CYP2D6, POR | MEN1 1230/4885KMT2A 2495/4885ALDH1A1 1286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.